Dialogue Jiang Xiaomeng: Using Enterprise Values to Realize Everlasting Foundation
Release time:
2021-11-22
11# May 15 to 19 . Jiang Xiaomeng, Chairman of Jinhua Federation of Industry and Commerce and Chairman of Jianfeng Group, appeared in the first program on 15 to talk about his understanding and feelings of "two health" and "common prosperity.
Moderator: 11
What kind of signal did the meeting on2
release, how do you interpret and view this issue?Jiang Xiaomeng: High-quality development and building a demonstration zone for common prosperity are the new glorious mission entrusted to Zhejiang by the Party Central Committee. This meeting fully affirmed the contribution made by the vast number of private enterprises to the economic development of Zhejiang, and at the same time put forward new hopes and requirements, requiring us to take the lead and set an example in the process of achieving common prosperity. give full play to the role of the new force of common prosperity, consciously devote ourselves to the macro scene of high-quality development, enhance the competitiveness of enterprises and the ability of modern operation, while strengthening, optimizing, and expanding enterprises, we should actively innovate, create wealth, pay taxes in accordance with the law, and increase employment. These are the most basic ways to achieve "getting rich first and then getting rich" or "getting rich first and then getting rich".
Moderator: As far as you know, what do entrepreneurs think of this new requirement?Jiang Xiaomeng: From the entrepreneurs I have met, although there are various understandings of common prosperity, we all realize that when the country and society develop to a certain extent, only when the people become prosperous together can the country be truly strong. As far as I personally understand it, common prosperity is not simply "equalizing the rich and the poor". From the perspective of enterprises, it is necessary to standardize operations, pay taxes in accordance with the law, and continue to innovate to ensure more stable and efficient development; for employees, they can no longer stay at the primary level of not defaulting on wages, but must establish and unblock employees' personal careers Career development channels, ensure the continuous and stable growth of employees' legal income, and ensure employees' physical and mental health and family harmony, this requires enterprises to formulate employees' health plans, pension plans and salary promotion plans, including physical examination, purchase of medical insurance for serious diseases, sympathy and assistance to needy employees, etc., which are all areas of common prosperity. To go further, we must have a high sense of social responsibility and mission, a sense of family and country, an ideal of serving the country, and the ability to create wealth and tax revenue for the country. These are the contents of our private enterprises participating in the cause of common prosperity.
Moderator: As an established company, how has Jianfeng achieved significant development in recent years?
Jiang Xiaomeng: With the continuous development and progress of society, technology and digitization have become an indispensable part of business operations and the only way for business development, so we have been taking technology and digitization as the direction of our efforts over the years. We have invested more than 20 million in the intelligent and digital transformation of the pharmaceutical sector. Through the workshop
DCS system,
EMSsystem, etc., we have realized the information collection, data monitoring and quality analysis of the production status, which not only improves the intelligent level, but also improves the labor productivity. For another example, our natural plant extraction digital workshop only needs to set relevant parameters on the control system, and the equipment can run automatically to achieve more accurate and efficient extraction of natural active ingredients. A workshop that used to require 10 or 20 employees is now less than five. In cement companies, we have also invested heavily in all-in-one card unattended, green intelligent mines, automatic batching, etc., and pollutant emissions are only a few tenths of the previous ones. In addition, our old vertical kiln cement plant used to have an annual output of 200 thousands or 300 thousands tons and 400 or 500 employees. After intelligent transformation, the annual output of the production line of ,200 tons, with about ,200 employees, is enough. If we go to our peak cement enterprises, whether in Hubei, Yunnan or Guizhou, from the working conditions to the factory environment, it is completely different from what we used to see. Host : After entering the era of 5G , there will be more and more smart enterprises, which will also give an old enterprise like us wings to take off. Is that right?
Jiang Xiaomeng: Yes. I can give two examples. First, we have continuously increased our investment in innovation over the years and have also received corresponding dividends. We have two national 1.1 new drugs with completely independent intellectual property rights and global innovation advantages. One of them is listed in the major new drug innovation project of the Ministry of science and technology of the people's Republic of China, and the other is the anti-tumor targeted drug in cooperation with returnees. This year, it has also entered the list of key innovation projects in Zhejiang Province. On the other hand, we rely on digitalization and technology, labor productivity has increased significantly. Host
: Because you have grasped these two main lines, constantly asking for efficiency from productivity, and constantly asking for productivity from digitalization and scientific and technological reform, although the peak is an old enterprise, it gives people a very young and energetic feeling. If you change your role, as president of the Federation of Industry and Commerce, what do you have to say to those companies that are in the early stages of development, or are still a little hesitant about the development of high-tech innovation?
Jiang Xiaomeng: I would like to say that for companies to continue to develop and progress, technological and digital upgrading is the only way to go, and those that leave will eventually be eliminated by history. The era of high-quality development has come, and every enterprise is trapped in it. Innovative development and high-quality development are the themes of the times for every Chinese enterprise.reporter connection: the just-concluded sixth Plenary session of the 19th CPC Central Committee proposed that China's economy has embarked on a road of higher quality, more efficient, fairer, more sustainable and safer development. As a private entrepreneur and chairman of the Jinhua Federation of Industry and Commerce, how do you understand this sentence, and at the same time as you develop yourself, how to drive more enterprises to embark on the road of higher quality and higher efficiency?
Jiang Xiaomeng: First, I will try my best to do my own business well. If my own business is not doing well, how can it be persuasive and influential? Therefore, as the chairman of Jianfeng Group, I should devote myself to running our company well and continue the current good development trend. Second, learn well. In today's era, science and technology are developing by leaps and bounds, and the progress of our enterprises is gradual. This "scissors gap" will bring about industrial changes. If you do not strengthen the learning of new knowledge, new ideas and new skills, you will be eliminated; keeping up is an opportunity. Therefore, I have to continuously learn these new skills and knowledge in order to help others. Third, good service. I would like to work with our colleagues in the Federation of Industry and Commerce to use our knowledge, ability and wisdom to help those enterprises in need, so that our enterprises in Jinhua can become stronger, bigger and better.
Our Federation of Industry and Commerce should also give full play to its own advantages, adhere to the promotion of the healthy development of Jinhua's private economy and the healthy growth of private economy as the main line of work, find the starting point for performing duties, grasp the focus of promotion, and make accurate efforts in publicity, service guidance, bridges and ties, etc. Further explore and carry out various activities that fit Jinhua private enterprises, and use this as a carrier to promote the exchange of ideas, and continuously strengthen the shaping and publicity of entrepreneurs to guide private enterprises to be the main force of economic construction and the vanguard of common prosperity. Only in this way can we leave our own stroke on the magnificent historical picture of "common prosperity. Host
: in the process of enterprise development, we will always encounter some problems of one kind or another. What kind of problems do you think Jinhua enterprises will encounter in the future and must face them together?
Jiang Xiaomeng: The development of an enterprise is gradual and wave-like. Each enterprise is in a different industry and has different market opportunities. The operating conditions will be good or bad. Don't feel too good when it is good., There is no need to be decadent when it is bad. For example, the price increase of coal, gas and other production resources this year has brought great pressure to enterprises. At this time, we have to keep calm and face up to the problem. You know, this problem is the whole industry, if you can improve technology, improve labor productivity, energy consumption down, competition will have an advantage. Similarly, when the business is going well, don't get carried away, rest on your laurels, or be arrogant, let alone "cover up all the ugliness" and fail to see your own defects. When we run a business, we must walk every step with trepidation and treading on thin ice.
host: let's talk about the future development of the peak. Where is the development goal of Pinnacle?
Jiang Xiaomeng: Our corporate vision is to "create a century-old pinnacle", and our company's development strategy is based on this vision, "Cooperation and innovation to strengthen the main business, standardize science and seek development". In other words, with the concept of cooperative innovation, the two main businesses of cement and medicine should be better and stronger; in addition, we are the earliest listed company in Zhejiang Province, and we must operate in accordance with the norms. Our two main businesses are cyclical and non-cyclical complementary, because the cement industry is greatly affected by national policy investment, and the pharmaceutical industry is related to human life and health and will not change with economic fluctuations. We must do a good job in these two industries and make cement cost-leading. It is not necessarily the largest company, but we must strive to become the most profitable company; the pharmaceutical sector must become a leader in the products of the sub-industry. Host
: Thank you for coming to the studio today to tell us about the development of the peak enterprise and your mission as chairman of the Federation of Industry and Commerce. Thank you.
(According to the program recording, there are abridged.)
As an enterprise, we must consistently adhere to the four values, that is, the value of people is higher than the value of things, the common value is higher than the personal value, the social value is higher than the profit value, and the user value is higher than the production value. I think that our majority of private enterprises also need to regard the above values as enterprise-oriented and long-term pursuit, so as to truly lead to the future they yearn for, stand in the forest of the industry, and realize the everlasting foundation.
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31